← The Wire
NVCRNasdaq
NovoCure Ltd
Surgical & Medical Instruments & Apparatus · CIK 1645113
NovoCure Ltd uses electric fields to kill cancer cells via a medical device
red 8-K · 90d⚡ Elevated coverage
$2.06B
Market cap
$15.48
Last close
+0.3%
1D
+13.7%
5D
1.1M
Volume
Price · last 39 sessions-8.6%
May 4L $13.61 · H $18.31Jun 29
189
Total filings
Jun 18, 2026
Last filing
12/31
Fiscal year end
8-KReg FD DisclosureJun 18, 20268-KExecutive Change · Shareholder VoteJun 5, 2026DEFA14ADEFA14AMay 21, 20268-KResults of OperationsApr 30, 202610-Q10-QApr 30, 20268-K/AExecutive ChangeApr 24, 2026DEFA14ADEFA14AApr 20, 2026DEF 14ADEF 14AApr 20, 20268-KExecutive ChangeApr 9, 20268-KReg FD DisclosureMar 26, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KReg FD DisclosureFeb 24, 20268-KReg FD DisclosureFeb 11, 20268-KReg FD DisclosureFeb 5, 20268-KResults of OperationsJan 12, 20268-KExecutive Change · Reg FD DisclosureDec 1, 202510-Q10-QOct 30, 20258-KResults of OperationsOct 30, 20258-KReg FD DisclosureSep 15, 20258-KReg FD DisclosureAug 28, 20258-KResults of OperationsJul 24, 202510-Q10-QJul 24, 20258-KExecutive Change · Shareholder VoteJun 6, 20258-KReg FD DisclosureJun 2, 20258-KResults of OperationsApr 24, 202510-Q10-QApr 24, 20258-KReg FD DisclosureApr 22, 2025DEFA14ADEFA14AApr 21, 2025DEF 14ADEF 14AApr 21, 20258-KResults of OperationsFeb 27, 202510-K10-KFeb 27, 20258-KResults of OperationsJan 13, 20258-K/AExecutive ChangeDec 17, 20248-KReg FD DisclosureDec 2, 20248-KExecutive Change · Results of OperationsOct 30, 202410-Q10-QOct 30, 20248-KReg FD DisclosureOct 15, 20248-KExecutive Change · Reg FD DisclosureSep 3, 202410-Q10-QJul 25, 20248-KResults of OperationsJul 25, 20248-KExecutive Change · Shareholder VoteJun 10, 20248-KReg FD DisclosureMay 20, 202410-Q10-QMay 2, 20248-KResults of OperationsMay 2, 2024DEFA14ADEFA14AApr 22, 2024DEF 14ADEF 14AApr 22, 20248-KReg FD DisclosureMar 27, 20248-KResults of OperationsFeb 22, 202410-K10-KFeb 22, 20248-KReg FD DisclosureJan 18, 20248-KReg FD DisclosureJan 9, 20248-KResults of OperationsJan 8, 20248-KExecutive Change · Reg FD DisclosureJan 4, 20248-KReg FD DisclosureNov 28, 20238-KResults of OperationsOct 26, 202310-Q10-QOct 26, 20238-KReg FD DisclosureAug 28, 20238-KResults of OperationsJul 27, 202310-Q10-QJul 27, 20238-KReg FD DisclosureJul 21, 20238-KExecutive Change · Shareholder VoteJun 8, 20238-KReg FD Disclosure · Company UpdateJun 6, 20238-KReg FD DisclosureJun 6, 20238-KReg FD Disclosure · Company UpdateJun 6, 20238-KResults of OperationsMay 4, 202310-Q10-QMay 4, 20238-KReg FD DisclosureApr 26, 2023DEFA14ADEFA14AApr 24, 2023DEF 14ADEF 14AApr 24, 20238-KExecutive ChangeMar 29, 202310-K10-KFeb 23, 20238-KResults of OperationsFeb 23, 20238-KResults of OperationsJan 9, 20238-KReg FD DisclosureJan 5, 20238-KCompany UpdateNov 4, 20228-KResults of OperationsOct 27, 202210-Q10-QOct 27, 20228-KResults of OperationsJul 28, 202210-Q10-QJul 28, 2022
Insider Activity
In the 90 days to Mar 5, 2026: 7 sold $2.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 2026 | Paravasthu MukundChief Operating Officer | Sell | 43,246 | $13.77 | $595K |
| Mar 4, 2026 | Weinberg UriChf Medical and Innovation Ofr | Sell | 6,412 | $13.31 | $85K |
| Mar 4, 2026 | Brackmann ChristophChief Financial Officer | Sell | 6,412 | $13.31 | $85K |
| Mar 4, 2026 | Leonard Frank XChief Executive Officer | Sell | 5,607 | $13.31 | $75K |
| Mar 4, 2026 | Paravasthu MukundChief Operating Officer | Sell | 5,377 | $13.31 | $72K |
| Mar 4, 2026 | Leupin NicolasFormer Chief Medical Officer | Sell | 1,100 | $13.31 | $15K |
| Mar 4, 2026 | Puri Michal NathChief Human Resources Officer | Sell | 1,100 | $13.31 | $15K |
| Mar 3, 2026 | Doyle William FExecutive Chairman | Sell | 50,557 | $12.79 | $647K |
| Mar 3, 2026 | Doyle William FExecutive Chairman | Sell | 21,330 | $13.43 | $286K |
| Mar 2, 2026 | Leonard Frank XChief Executive Officer | Sell | 7,232 | $13.49 | $98K |
| Mar 2, 2026 | Weinberg UriChf Medical and Innovation Ofr | Sell | 3,272 | $13.33 | $44K |
| Mar 2, 2026 | Paravasthu MukundChief Operating Officer | Sell | 408 | $13.49 | $6K |
| Feb 27, 2026 | Leonard Frank XChief Executive Officer | Sell | 9,734 | $13.66 | $133K |
| Feb 27, 2026 | Weinberg UriChf Medical and Innovation Ofr | Sell | 7,461 | $13.84 | $103K |
| Feb 27, 2026 | Paravasthu MukundChief Operating Officer | Sell | 1,555 | $13.66 | $21K |
| Feb 27, 2026 | Puri Michal NathChief Human Resources Officer | Sell | 1,441 | $13.66 | $20K |
| Feb 27, 2026 | Leupin NicolasFormer Chief Medical Officer | Sell | 1,029 | $13.66 | $14K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 1 reputable article · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance